Related Experiment Videos
Renal functional response to captopril during diuretic therapy
1Department of Nuclear Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York 10461.
Summary
Diuretic therapy does not significantly alter the renal effects of angiotensin converting enzyme inhibitors (ACEI) in renovascular hypertension models. This finding is crucial for accurately diagnosing renovascular hypertension when patients are on diuretics.
Area of Science:
- Nephrology
- Pharmacology
- Cardiovascular Research
Background:
- Antihypertensive agents can influence the renal effects of angiotensin converting enzyme inhibition (ACEI).
- Understanding these interactions is vital for diagnosing renovascular hypertension, particularly in patients using diuretics.
Purpose of the Study:
- To investigate the impact of diuretic pretreatment on the renal response to ACEI in rat models of renovascular hypertension.
- To determine if diuretic therapy interferes with the diagnostic utility of ACEI in renovascular hypertension.
Main Methods:
- Two rat models were used: one-kidney, one-clip (1K1C) and two-kidney, one-clip (2K1C).
- Animals received intravenous or intraperitoneal diuretics (furosemide, hydrochlorothiazide, chlorothiazide) before ACEI administration.
- Glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were measured.
Main Results:
- Acute diuretics did not alter GFR or ERPF in 1K1C rats, but ACEI after diuretics reduced GFR.
- Chronic hydrochlorothiazide in 1K1C rats decreased both GFR and ERPF.
- In 2K1C rats, ACEI reduced GFR and ERPF in the clamped kidney and increased contralateral ERPF.
- The impact of ACEI on GFR was comparable with or without prior diuretic treatment.
Conclusions:
- Diuretic therapy does not significantly interfere with the evaluation of renovascular hypertension using ACEI.
- The renal hemodynamic consequences of ACEI on GFR are consistent regardless of diuretic use.
- These findings support the continued use of ACEI in assessing renovascular hypertension in patients on diuretic therapy.